To evaluate the clinical value of chromosome microarray analysis (CMA) and whole-exome sequencing (WES) for fetuses with skeletal dysplasia with or without other structural abnormalities. Methods: Karyotyping and CMA were performed on 50 fetuses with skeletal dysplasia with or without other structural abnormalities from January 2016 to December 2017. WES was performed on 11 fetuses with normal karyotype and CMA results, among which eight were fetus-mother-father samples and three were proband-only samples. Results: Overall, 6% (3/50) of the fetal cases had an abnormal karyotype. After removing three abnormal karyotypes, pathogenic copy number variations (CNVs) were detected in 16% (8/50) of the fetuses that underwent CMA. Variants of uncertain significance (VOUS) and benign CNVs comprised 12% (6/50) and 6% (3/50) of the tested fetuses, respectively. WES revealed the genetic variants responsible for the abnormal phenotypes in seven cases (63.6%, 7/11). We detected pathogenic variants of seven genes, MESP2, KAT6B, two of COL1A2, MYH3, TCIRG1, SCN5A and CPT2, of which the latter two genes were from the same case, and one gene, COL11A2, was of uncertain significance. The diagnostic rate of WES was significantly higher than that of CMA (P<0.05). There was no significant difference in the diagnostic rates of CMA and WES between the isolated and non-isolated skeletal dysplasia groups (P=0.307 for CMA; P=0.237 for WES). Conclusions: Fetuses with skeletal dysplasia are more likely to have genetic variants than pathogenic CNVs. WES is a promising method for the identification of genetic variants that cause skeletal dysplasia with or without other structural abnormalities.
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Objective evaluation of fetal facial morphology using a new method: facial shape index
R. Sunami
Obstetrics, Yamanashi, Prefectural Central Hospital, Kofu, Yamanashi, Japan Objectives: The aim of this study was to evaluate the feasibility of objective assessment of fetal facial morphology using new index of combined several measurements defining facial characteristic obtained from 3D ultrasound volumes. Methods: 3D volumes of fetal head were acquired at two directions of sagittal and axial section in 249 fetuses (234 from normal cases and 15 from pathological cases) at between 22 to 28 weeks of gestation. After assessing reproducibility, maxilla-nasion-mandible (MNM) angle, sellion-upper lip (SL) angle, frontal height (defined as the vertical distance from the line tangential to frontal bone passing nasion), facial height (defined as the distance from nasion to gnathion), nasal height, nasal length and lip were measured in the exact mid-sagittal plane.
Inner and outer orbital diameter, nasal root height and nasal width were measured in the axial plane at each level. After normalising with head circumference, Z score of all measurements were calculated. Facial shape index (FSI) was defined as the sum of these Z score. We compared FSI in 15 pathological cases with normal cases, and determined cut-off value for use in screening by ROC curves. Results: The mean value of facial height, frontal height, nasal height, nasal width, nasal root height, inner and outer orbital diameter normalising with head circumference was 1.6±0.1, 2.0±0.2, 1.7±0.2, 6.0±0.5, 7.0±0.5,1.1±0.2, 5.6±0.4, 17±0.7, 1.6±0.3 and 1.1±0.2, respectively. The mean MNM angle was 9. 
Methods:
The fetal-MRI database was retrospectively searched for congenital CMV infections. Forty cases of primary CMV infection during pregnancy were included; three cases had a follow-up MRI performed between 6 days to 10.5 weeks after the first examination. Images were reviewed by one neuroradiologist and one radiology resident for placental and fetal extracerebral and intracerebral findings, blinded to the MR and US reports. The findings were later compared with the clinical MR report for missed findings. Results: The mean gestational age was 29.8 weeks with a maximum of 38 weeks and a minimum of 21 weeks. In seven cases (17.5%) no abnormalities in either the brain, the body or the placenta were found. In 18 cases (45.0%) brain abnormalities were found. Twenty-six cases (65.0%) showed abnormalities in the body, mainly involving the fetal liver, and 25 cases (62.5%) in the placenta. Two of three cases with follow-up didn't show significant changes in the second examination, with one case showing aggravation of the brain and placental changes, as well as new body abnormalities.
Conclusions:
In the course of a FIRS associated with CMV extracerebral findings are very common, in fetuses with maternal primary CMV infection during pregnancy, and could potentially be used as an MR biomarker for this disease, initiating further monitoring of fetal and postnatal brain development in these cases.
OC20.05
Image review for quality of the first trimester anomaly scan 
